Download PDF
Int J Sports Med 2011; 32(6): 461-467
DOI: 10.1055/s-0031-1271697
Clinical Sciences

© Georg Thieme Verlag KG Stuttgart · New York

Exercise Training and Cytokines in Breast Cancer Survivors

A. M. Gómez1 , [*] , C. Martínez1 , [*] , C. Fiuza-Luces2 , F. Herrero3 , M. Pérez2 , L. Madero1 , J. R. Ruiz4 , 5 , A. Lucia2 , [*] , M. Ramírez1 , [*]
  • 1Hospital Infantil Universitario Niño Jesús, Oncologia, Madrid, Spain
  • 2Universidad Europea de Madrid, Biomedicine, Madrid, Spain
  • 3Ayuntamiento de Miranda de Ebro, Sports Medicine, Miranda, Spain
  • 4Unit for Preventive Nutrition, Karolinska Institutet, Department of Biosciences and Nutrition at NOVUM, Huddinge, Sweden
  • 5Department of Physical Activity and Sport Sciences, University of Granada, Spain
Further Information

Publication History

accepted after revision January 12, 2011

Publication Date:
04 March 2011 (online)

Also available at
    Permissions and Reprints

Abstract

The purpose of this randomized controlled trial was to determine the effects of an 8-week (aerobic+strength) exercise training program (3 sessions/week) on the circulating cytokine levels of breast cancer survivors. We randomly allocated 16 female survivors of breast cancer (mean±SD age: 50±5 years) to an intervention or usual care (control) group (N=8 in each group). The intervention group followed an 8-week exercise program consisting of 3 sessions/week (session duration: 90 min). We measured the levels of the following cytokines before and after the intervention: beta-NGF, CTACK, eotaxin, FGF basic, G-CSF, gmCSFα, HGF, ICAM1, IFNα2, IFNγ, IL1α, IL1ß, IL1ra, IL2, IL2ra, IL3, IL4, IL6, IL7, IL8, IL9, IL10, IL12, IL13, IL15, IL16, IL17, IL18, IP10, LIF, MCS-F, MIP1α, MIP1β, MIF, MCP1, MCP3, MIG, PDGF bb, SCF, SCGFβ, SDF1α, TRAIL, TNFα, TNFβ, VCAM1, and VEGF. We only observed a significant interaction (group*time) effect for CTACK (P=0.016), with mean values remaining stable in the intervention group but increasing over time in controls. The intervention program did not induce a significant decrease in the main breast cancer-related cytokines such as IL6 and IL8. A combined (aerobic+strength) 8-week exercise training intervention did not induce major changes in the basal cytokine levels of breast cancer survivors.

Key words

physical activity - inflammation - tumour - interleukins

References

  • 1 Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.  J Am Coll Cardiol. 2002;  39 653-663
    CrossrefPubMedGoogle Scholar
  • 2 Bacurau RF, Belmonte MA, Seelaender MC, Costa Rosa LF. Effect of a moderate intensity exercise training protocol on the metabolism of macrophages and lymphocytes of tumour-bearing rats.  Cell Biochem Funct. 2000;  18 249-258
    CrossrefPubMedGoogle Scholar
  • 3 Bach JP, Deuster O, Balzer-Geldsetzer M, Meyer B, Dodel R, Bacher M. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors.  Cancer. 2009;  115 2031-2040
    CrossrefPubMedGoogle Scholar
  • 4 Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.  Clin Cancer Res. 2004;  10 7157-7162
    CrossrefPubMedGoogle Scholar
  • 5 Borish LC, Steinke JW. 2. Cytokines and chemokines.  J Allergy Clin Immunol. 2003;  111 S460-S475
    CrossrefPubMedGoogle Scholar
  • 6 Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation.  J Leukoc Biol. 2005;  78 819-835
    CrossrefPubMedGoogle Scholar
  • 7 Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity.  Nat Rev Immunol. 2003;  3 791-800
    CrossrefPubMedGoogle Scholar
  • 8 Conraads VM, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, Brutsaert DL. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease.  Eur Heart J. 2002;  23 1854-1860
    CrossrefPubMedGoogle Scholar
  • 9 Coussens LM, Werb Z. Inflammation and cancer.  Nature. 2002;  420 860-867
    CrossrefPubMedGoogle Scholar
  • 10 Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB. Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis.  Med Sci Sports Exerc. 2008;  40 618-621
    CrossrefPubMedGoogle Scholar
  • 11 DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.  Breast Cancer Res. 2007;  9 212
    CrossrefPubMedGoogle Scholar
  • 12 Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.  Cancer Res. 1995;  55 4988-4994
    PubMedGoogle Scholar
  • 13 Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients.  Int J Cardiol. 2005;  100 93-99
    CrossrefPubMedGoogle Scholar
  • 14 Harriss DJ, Atkinson G. International Journal of Sports Medicine – Ethical Standards in Sport and Exercise Science Research.  Int J Sports Med. 2009;  30 701-702
    Google Scholar
  • 15 Herrero F, San Juan AF, Fleck SJ, Balmer J, Perez M, Canete S, Earnest CP, Foster C, Lucia A. Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial.  Int J Sports Med. 2006;  27 573-580
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Holm S. A simple sequentially rejective multiple test procedure.  Scand J Statist. 1979;  6 65-70
    PubMedGoogle Scholar
  • 17 Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.  Nat Med. 2002;  8 157-165
    CrossrefPubMedGoogle Scholar
  • 18 Irwin ML. Physical activity interventions for cancer survivors.  Br J Sports Med. 2009;  43 32-38
    CrossrefPubMedGoogle Scholar
  • 19 Jiang XP, Yang DC, Elliott RL, Head JF. Reduction in serum IL-6 after vaccination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status.  Cytokine. 2000;  12 458-465
    CrossrefPubMedGoogle Scholar
  • 20 Jung SH, Park HS, Kim KS, Choi WH, Ahn CW, Kim BT, Kim SM, Lee SY, Ahn SM, Kim YK, Kim HJ, Kim DJ, Lee KW. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss.  J Nutr Biochem. 2008;  19 371-375
    CrossrefPubMedGoogle Scholar
  • 21 Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.  Rocz Akad Med Bialymst. 2003;  48 82-84
    PubMedGoogle Scholar
  • 22 Kraynyak KA, Kutzler MA, Cisper NJ, Khan AS, Draghia-Akli R, Sardesal NY, Lewis MG, Yan J, Weiner DB. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.  Vaccine. 2010;  28 1942-1951
    CrossrefPubMedGoogle Scholar
  • 23 Lira FS, Rosa JC, Zanchi NE, Yamashita AS, Lopes RD, Lopes AC, Batista Jr ML, Seelaender M. Regulation of inflammation in the adipose tissue in cancer cachexia: effect of exercise.  Cell Biochem Funct. 2009;  27 71-75
    CrossrefPubMedGoogle Scholar
  • 24 Lucia A, Earnest C, Perez M. Cancer-related fatigue: can exercise physiology assist oncologists?.  Lancet Oncol. 2003;  4 616-625
    CrossrefPubMedGoogle Scholar
  • 25 Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action.  J Biol Chem. 1999;  274 18100-18106
    CrossrefPubMedGoogle Scholar
  • 26 Munger W, DeJoy SQ, Jeyaseelan Sr R, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwar SS. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2.  Cell Immunol. 1995;  165 289-293
    CrossrefPubMedGoogle Scholar
  • 27 Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Mizumoto T, Hamamoto R. An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer.  Oncology. 2000;  59 166-173
    CrossrefPubMedGoogle Scholar
  • 28 Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Bluher M. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.  Eur J Endocrinol. 2006;  154 577-585
    CrossrefPubMedGoogle Scholar
  • 29 Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise.  J Appl Physiol. 2005;  98 1154-1162
    CrossrefPubMedGoogle Scholar
  • 30 Polak J, Klimcakova E, Moro C, Viguerie N, Berlan M, Hejnova J, Richterova B, Kraus I, Langin D, Stich V. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.  Metabolism. 2006;  55 1375-1381
    CrossrefPubMedGoogle Scholar
  • 31 Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.  Int J Cancer. 2003;  103 642-646
    CrossrefPubMedGoogle Scholar
  • 32 Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP. Weight lifting in women with breast-cancer-related lymphedema.  N Engl J Med. 2009;  361 664-673
    CrossrefPubMedGoogle Scholar
  • 33 Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer.  Nat Rev Cancer. 2008;  8 887-899
    CrossrefPubMedGoogle Scholar
  • 34 Timmons BW, Hamadeh MJ, Tarnopolsky MA. Two methods for determining plasma IL-6 in humans at rest and following exercise.  Eur J Appl Physiol. 2009;  105 13-18
    CrossrefPubMedGoogle Scholar
  • 35 Verjans E, Noetzel E, Bektas N, Schutz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.  BMC Cancer. 2009;  9 230
    CrossrefPubMedGoogle Scholar
  • 36 Yu YL, Wei CW, Chen YL, Chen MH, Yiang GT. Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression.  Int J Oncol. 2010;  36 365-370
    PubMedGoogle Scholar

1 A. M. Gómez and C. Martínez contributed equally to this paper and A. Lucia and A. Ramírez share senior authorship.

Correspondence

Prof. Alejandro Lucia

Universidad Europea De Madrid

Physiology

Villaviciosa de Odón

28670 Madrid

Spain

Phone: + 34/91/6647 800

Fax: + 34/91/6168 265

Email: alejandro.lucia@uem.es

      >